UPDATE 1-FDA approves Pfizer’s drug for rare blood cancer

Aug 17 (Reuters) – The U.S. Food and Drug Administration(FDA) said on Thursday it approved Pfizer Inc’s rareblood cancer drug, Besponsa, with a boxed warning.
The post UPDATE 1-FDA approves Pfizer’s drug for rare blood cancer appeared first on RocketNews | Top News Stories From Around the Globe.